An article that appeared in October edition of Cleanroom Technology Magazine The trouble with biological indicators. Understanding the challenge. The solution to continuous monitoring of “fragile” hydrogen peroxide decontamination processes. The trouble with biological indicators. For nearly forty years the pharmaceutical and healthcare sectors have used cold gaseous processes to deliver a decontamination of environments…
The Editor of Cleanroom Technology caught up with Phillip Godden, founder and CEO at Protak about the use of this new technology and its support from the MHRA Previously the healthcare and pharmaceutical sectors used cold, gaseous processes to decontaminate environments. Likely the most notable of these methods is the hydrogen peroxide decontamination cycle, which offers excellent…
Phillip Godden, CEO of Protak Scientific has been awarded the coveted Pharmaceutical CEO of the Year 2018 by GHP magazine. The award recognises Phillip’s work in bringing Enzymatic Indicators to the pharmaceutical industry. Phillip is hugely passionate about bringing this technology to market as he believes it will revolutionise the medical and pharmaceutical industries’ approach to Decontamination Validation.…
The MHRA have agreed to assist Protak Scientific in the formation of a UK focus group to discuss the use of Enzyme Indicators in the UK. The MHRA have seen the potential of the use of Enzymatic Indicators to measure Decontamination Validation and are open to discuss the regulation process with the group. Meetings will be via Social…